Levi A. Garraway

La Roche College

Full Professor(heuristic)

Cancer Genomics and Diagnostics · Cancer Research

h-index147
i10-index277
Publications1,020
Citations150,688

Grants

50 total · 0 active

NIH #3R35CA197737-01S1

Overcoming resistance to targeted therapy in cancer

Amount
$71K
Period
2015-08-24 → 2022-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #1R35CA197737-01

Overcoming resistance to targeted therapy in cancer

Amount
$473K
Period
2015-08-24 → 2022-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5P50CA090381-15

Genomic Determinants of Resistance to Primary Androgen Deprivation Therapy and A

Amount
$261K
Period
2002-09-19 → 2019-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

50 total · 0 active

NIH #3R35CA197737-01S1

Overcoming resistance to targeted therapy in cancer

Amount
$71K
Period
2015-08-24 → 2022-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #1R35CA197737-01

Overcoming resistance to targeted therapy in cancer

Amount
$473K
Period
2015-08-24 → 2022-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5P50CA090381-15

Genomic Determinants of Resistance to Primary Androgen Deprivation Therapy and A

Amount
$261K
Period
2002-09-19 → 2019-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5P50CA127003-10

Overcoming Resistance to RAF Inhibition in BRAF-Mutant Colorectal Cancer

Amount
$255K
Period
2007-08-31 → 2019-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5U10CA180861-04

ITSC for Leukemia: Novel Molecular Strategies for NCTN: "Individualized" Therapie

Amount
$644K
Period
2014-05-02 → 2019-02-28
PIs
4
Est. capacity / PI
~0 students

Awarded at OHIO STATE UNIVERSITY

NIH #5P01CA163222-05

Defining and Modeling Resistance to RAF/MEK Inhibition in Human Melanoma

Amount
$389K
Period
— → 2019-02-28
PIs
1
Est. capacity / PI
~6 students

Awarded at MASSACHUSETTS GENERAL HOSPITAL

NIH #5U10CA180861-03

ITSC for Leukemia: Novel Molecular Strategies for NCTN: "Individualized" Therapie

Amount
$687K
Period
2014-05-02 → 2019-02-28
PIs
4
Est. capacity / PI
~0 students

Awarded at OHIO STATE UNIVERSITY

NIH #5U10CA180861-02

ITSC for Leukemia: Novel Molecular Strategies for NCTN: "Individualized" Therapie

Amount
$691K
Period
2014-05-02 → 2019-02-28
PIs
4
Est. capacity / PI
~0 students

Awarded at OHIO STATE UNIVERSITY

NIH #1U10CA180861-01

ITSC for Leukemia: Novel Molecular Strategies for NCTN: "Individualized" Therapie

Amount
$700K
Period
2014-05-02 → 2019-02-28
PIs
4
Est. capacity / PI
~0 students

Awarded at OHIO STATE UNIVERSITY

NIH #5P50CA127003-07

Overcoming Resistance to RAF Inhibition in BRAF-Mutant Colorectal Cancer

Amount
$239K
Period
2007-08-31 → 2018-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #2P50CA127003-06A1

Overcoming Resistance to RAF Inhibition in BRAF-Mutant Colorectal Cancer

Amount
$238K
Period
2007-08-31 → 2018-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #2P50CA090381-11A1

Genomic Determinants of Resistance to Primary Androgen Deprivation Therapy and A

Amount
$242K
Period
2002-09-19 → 2018-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #1P01CA163222-01A1

Defining and Modeling Resistance to RAF/MEK Inhibition in Human Melanoma

Amount
$681K
Period
2013-03-12 → 2018-02-28
PIs
1
Est. capacity / PI
~0 students

Awarded at MASSACHUSETTS GENERAL HOSPITAL

NIH #5R35CA197737-02

Overcoming resistance to targeted therapy in cancer

Amount
$831K
Period
2015-08-24 → 2017-12-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #3R35CA197737-02S1

Overcoming resistance to targeted therapy in cancer

Amount
$87K
Period
2015-08-24 → 2017-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5U01CA162148-03

Systematic Genetic Characterization of African American Prostate Cancer

Amount
$332K
Period
2012-07-15 → 2017-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5U01CA162148-02

Systematic Genetic Characterization of African American Prostate Cancer

Amount
$324K
Period
2012-07-15 → 2017-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #1U01CA162148-01A1

Systematic Genetic Characterization of African American Prostate Cancer

Amount
$347K
Period
2012-07-15 → 2017-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #3U01HG006492-04S1

The Use of Whole-Exome Sequencing to Guide the Care of Cancer Patients

Amount
$73K
Period
2012-02-10 → 2017-05-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5U01CA162148-04

Systematic Genetic Characterization of African American Prostate Cancer

Amount
$337K
Period
2012-07-15 → 2016-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5P50CA127003-08

Overcoming Resistance to RAF Inhibition in BRAF-Mutant Colorectal Cancer

Amount
$247K
Period
2007-08-31 → 2016-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5P50CA090381-13

Genomic Determinants of Resistance to Primary Androgen Deprivation Therapy and A

Amount
$242K
Period
2002-09-19 → 2016-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5P01CA163222-03

Defining and Modeling Resistance to RAF/MEK Inhibition in Human Melanoma

Amount
$626K
Period
— → 2016-02-29
PIs
1
Est. capacity / PI
~10 students

Awarded at MASSACHUSETTS GENERAL HOSPITAL

NIH #5U01HG006492-03

The Use of Whole-Exome Sequencing to Guide the Care of Cancer Patients

Amount
$1.5M
Period
2012-02-10 → 2015-11-30
PIs
2
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5U01HG006492-02

The Use of Whole-Exome Sequencing to Guide the Care of Cancer Patients

Amount
$1.4M
Period
2012-02-10 → 2015-11-30
PIs
2
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #1U01HG006492-01

The Use of Whole-Exome Sequencing to Guide the Care of Cancer Patients

Amount
$1.5M
Period
2012-02-10 → 2015-11-30
PIs
2
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R33CA155554-03

High-Throughput Tumor Genomic Profiling by Massively Parallel Sequencing

Amount
$229K
Period
2011-09-20 → 2015-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R33CA155554-02

High-Throughput Tumor Genomic Profiling by Massively Parallel Sequencing

Amount
$263K
Period
2011-09-20 → 2014-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #1R33CA155554-01

High-Throughput Tumor Genomic Profiling by Massively Parallel Sequencing

Amount
$225K
Period
2011-09-20 → 2014-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R33CA126674-04

High-throughput oncogene mutation detection in human cancer

Amount
$315K
Period
2007-08-01 → 2013-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #1DP2OD002750-01

Defining Melanoma Therapeutic Avenues by Integrative Functional Genomics

Amount
$2.6M
Period
2007-09-30 → 2012-08-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #4R33CA126674-03

High-throughput oncogene mutation detection in human cancer

Amount
$292K
Period
2007-08-01 → 2012-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R21CA126674-02

High-throughput oncogene mutation detection in human cancer

Amount
$205K
Period
2007-08-01 → 2010-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5K08CA115927-05

Integrated Functional Genomic Analyses of Melanoma

Amount
$137K
Period
2005-07-01 → 2010-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5K08CA115927-04

Integrated Functional Genomic Analyses of Melanoma

Amount
$137K
Period
2005-07-01 → 2010-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5K08CA115927-03

Integrated Functional Genomic Analyses of Melanoma

Amount
$137K
Period
2005-07-01 → 2010-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5K08CA115927-02

Integrated Functional Genomic Analyses of Melanoma

Amount
$137K
Period
2005-07-01 → 2010-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #1K08CA115927-01

Integrated Functional Genomic Analyses of Melanoma

Amount
$137K
Period
2005-07-01 → 2010-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #2R01CA085912-06

Functional Analysis of the PTEN Tumor Suppressor Protein

Amount
$280K
Period
2000-06-01 → 2010-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R01CA085912-10

Functional Analysis of the PTEN Tumor Suppressor Protein

Amount
$266K
Period
2000-06-01 → 2010-04-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R01CA085912-09

Functional Analysis of the PTEN Tumor Suppressor Protein

Amount
$266K
Period
2000-06-01 → 2010-04-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R01CA085912-08

Functional Analysis of the PTEN Tumor Suppressor Protein

Amount
$267K
Period
2000-06-01 → 2010-04-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #5R01CA085912-07

Functional Analysis of the PTEN Tumor Suppressor Protein

Amount
$274K
Period
2000-06-01 → 2010-04-30
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #1R21CA126674-01

High-throughput oncogene mutation detection in human cancer

Amount
$171K
Period
2007-08-01 → 2009-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at DANA-FARBER CANCER INST

NIH #4P50CA090381-14

Genomic Determinants of Resistance to Primary Androgen Deprivation Therapy and A

Amount
$241K
Period
2002-09-19 → —
PIs
1
Est. capacity / PI
~4 students

Awarded at DANA-FARBER CANCER INST

NIH #4P50CA127003-09

Overcoming Resistance to RAF Inhibition in BRAF-Mutant Colorectal Cancer

Amount
$240K
Period
2007-08-31 → —
PIs
1
Est. capacity / PI
~3 students

Awarded at DANA-FARBER CANCER INST

NIH #4P01CA163222-04

Defining and Modeling Resistance to RAF/MEK Inhibition in Human Melanoma

Amount
$628K
Period
— → —
PIs
1
Est. capacity / PI
~10 students

Awarded at MASSACHUSETTS GENERAL HOSPITAL

NIH #5P01CA163222-02

Defining and Modeling Resistance to RAF/MEK Inhibition in Human Melanoma

Amount
$607K
Period
— → —
PIs
1
Est. capacity / PI
~10 students

Awarded at MASSACHUSETTS GENERAL HOSPITAL

NIH #5P50CA090381-12

Genomic Determinants of Resistance to Primary Androgen Deprivation Therapy and A

Amount
$232K
Period
2002-09-19 → —
PIs
1
Est. capacity / PI
~3 students

Awarded at DANA-FARBER CANCER INST

NIH #5F31HG000092-07

MOLECULAR GENETICS OF PARASITE VIRULENCE

Amount
$16K
Period
1998-09-08 → —
PIs
1
Est. capacity / PI
~0 students

Awarded at HARVARD MEDICAL SCHOOL

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 10 of 10
Open author page on OpenAlex →